This inventor holds 3 USPTO granted patents. Top assignees: Panmedix, Inc., Biogen Idec Ma Inc.. Active years: 2005-2017.
Company Filing History:
Years Active: 2005-2017
Title: David Erlanger: Innovator in Neurological Diagnostics
Introduction
David Erlanger is a notable inventor based in New York, NY (US). He has made significant contributions to the field of neurological diagnostics, holding a total of 3 patents. His work focuses on innovative methods and systems that enhance the evaluation and treatment of neurological conditions.
Latest Patents
Erlanger's latest patents include "Cognitive composite parameters and uses thereof for evaluating multiple sclerosis." This invention discloses methods, systems, and kits for the identification, assessment, and treatment of individuals with multiple sclerosis. Another significant patent is "Neurological pathology diagnostic apparatus and methods." This invention provides apparatus and methods for rapidly diagnosing the presence or absence of symptoms related to neurological pathology caused by various factors, including physical head trauma, disease, toxins, or infection. These inventions are crucial for diagnosing neurological conditions and monitoring recovery.
Career Highlights
Throughout his career, David Erlanger has worked with prominent companies such as Panmedix, Inc. and Biogen Idec. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of neurological diagnostics.
Collaborations
Erlanger has collaborated with notable professionals in his field, including Alexis Theodoracopulos and Philip Yee. These collaborations have contributed to the advancement of his inventions and the impact they have on neurological health.
Conclusion
David Erlanger's contributions to neurological diagnostics through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the evaluation and treatment of neurological conditions.